paraproteinemia (monoclonal gammopathy)

From Aaushi
Jump to navigation Jump to search

Etiology

Pathology

Laboratory

* combination has sensitivity of ~100% diagnosing multiple myeloma requiring therapy

Diagnostic procedures

Radiology

More general terms

More specific terms

References

  1. Bataille R, Harousseau JL. Multiple myeloma. N Engl J Med. 1997 Jun 5;336(23):1657-64. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/9171069
  2. Veterans Administration, Mather CA
  3. UpToDate 14.1 (2007) http://www.utdol.com
  4. 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Medical Knowledge Self Assessment Program (MKSAP) 17, 18, 19. American College of Physicians, Philadelphia 2015, 2018, 2022
  5. Katzmann JA, Kyle RA, Benson J et al Screening panels for detection of monoclonal gammopathies. Clin Chem. 2009 Aug;55(8):1517-22 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19520758
  6. Zivkovic SA, Lacomis D, Lentzsch S. Paraproteinemic neuropathy. Leuk Lymphoma. 2009 Sep;50(9):1422-33 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19637090
  7. Rison RA, Beydoun SR. Paraproteinemic neuropathy: a practical review. BMC Neurol. 2016 Jan 28;16:13. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26821540 Free PMC Article
  8. Rosner MH, Edeani A, Yanagita M et al Paraprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance. Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2280-2287. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27526705 Free PMC Article